| Value | ₹89.76 Cr |
|---|
BSE filing, NSE: SRDAPRT. Summary written from the filing by ALFA Finder's alert engine.
Fresita Proteins Ltd: key numbers
- Share price
- ₹136.60
- Market cap
- ₹122.6 Cr
- Revenue (annual)
- ₹16.16 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 43.9×Sector 38.6×
- Promoter holding
- 80.47%-0.19% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fresita Proteins Ltd
All →Fresita Proteins Board Meeting Date
Fresita Proteins intimated a Rights Issue Committee meeting on October 26, 2026, to finalize its ₹90 Crore rights issue terms. No decisions have been made yet.
Fresita Proteins Annual General Meeting
Fresita Proteins Limited concluded its 35th Annual General Meeting on September 30, 2026. Shareholders transacted five resolutions, including approval for borrowing and investment limits of ₹1,000 Crore each.
Sarda Proteins Price Movement Clarification
Sarda Proteins Limited responded to a BSE query regarding recent stock price movement. The company stated the fluctuations are driven by market forces and conditions.
Sarda Proteins Other Announcement
Sarda Proteins Limited has changed its name to Fresita Proteins Limited, effective September 21, 2026. The name change received approval from the Ministry of Corporate Affairs and BSE.
Sarda Proteins Annual Report
Sarda Proteins Limited filed its 35th Annual Report for the financial year ended 31st March 2026 with the stock exchange.
Sarda Proteins Annual General Meeting
Sarda Proteins set its 35th AGM for September 30, 2026, with book closure September 24–30. E-voting cut-off date is September 23, 2026.
Other capital structure change announcements
All →Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Womancart Capital Structure Change
Womancart Limited submitted its draft letter of offer for a rights issue of up to Rs.1,200 lakhs to eligible shareholders. The issue is pending in-principle approval from NSE Emerge, with the price, ratio and dates still blank.
- Value
- ₹12.00 Cr
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Blue Chip Tex Industries Capital Structure Change
Counter Cyclical Investments PMS sold 2,986 shares (0.15%) of Blue Chip Tex via open market, reducing its stake from 5.62% to 5.46%. The filing is a non-promoter SAST Reg 29(2) disclosure.